Summary
This Form 8-K/A filing by Quest Diagnostics Incorporated (DGX) serves as an amendment to a prior report, specifically addressing the frequency of advisory votes on executive compensation. The amendment clarifies the company's decision following the results of a stockholder vote at the 2011 annual meeting. Investors should note that this filing does not introduce new financial results or operational updates but rather pertains to corporate governance procedures. The Board of Directors has determined that Quest Diagnostics will hold an annual advisory vote on executive compensation. This decision is in response to the stockholder vote at the 2011 meeting and will continue until the next required vote on compensation frequency, which must occur no less than every six years. This ensures ongoing stockholder input on executive pay practices.
Key Highlights
- 1This filing is an amendment (Form 8-K/A) to a previous filing dated May 20, 2011.
- 2The sole purpose of this amendment is to disclose the company's decision on the frequency of advisory votes on executive compensation.
- 3Quest Diagnostics' Board of Directors has decided to hold an annual advisory vote on executive compensation.
- 4This decision follows the voting results from the Company's 2011 annual meeting of stockholders.
- 5The annual advisory vote on executive compensation will continue until the next required vote on frequency, which is mandated at least every six years.
- 6No other changes or updates were made to the original filing.